MONOTHERAPY WITH MEROPENEM VERSUS COMBINATION THERAPY WITH CEFTAZIDIME PLUS AMIKACIN AS EMPIRIC THERAPY FOR FEVER IN GRANULOCYTOPENIC PATIENTS WITH CANCER. THE INTERNATIONAL ANTIMICROBIAL THERAPY COOPERATIVE GROUP OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER AND THE GRUPPO ITALIANO MALATTIE EMATOLOGICHE MALIGNE DELL'ADULTO INFECTION PROGRAM

COMETTA, A., CALANDRA, T., & NAGAYA, H.. (1996). MONOTHERAPY WITH MEROPENEM VERSUS COMBINATION THERAPY WITH CEFTAZIDIME PLUS AMIKACIN AS EMPIRIC THERAPY FOR FEVER IN GRANULOCYTOPENIC PATIENTS WITH CANCER. THE INTERNATIONAL ANTIMICROBIAL THERAPY COOPERATIVE GROUP OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER AND THE GRUPPO ITALIANO MALATTIE EMATOLOGICHE MALIGNE DELL'ADULTO INFECTION PROGRAM. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 40(-), 1108-1115. SID. https://sid.ir/paper/558941/en

COMETTA A., CALANDRA T., NAGAYA H.. MONOTHERAPY WITH MEROPENEM VERSUS COMBINATION THERAPY WITH CEFTAZIDIME PLUS AMIKACIN AS EMPIRIC THERAPY FOR FEVER IN GRANULOCYTOPENIC PATIENTS WITH CANCER. THE INTERNATIONAL ANTIMICROBIAL THERAPY COOPERATIVE GROUP OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER AND THE GRUPPO ITALIANO MALATTIE EMATOLOGICHE MALIGNE DELL'ADULTO INFECTION PROGRAM. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY[Internet]. 1996;40(-):1108-1115. Available from: https://sid.ir/paper/558941/en

A. COMETTA, T. CALANDRA, and H. NAGAYA, “MONOTHERAPY WITH MEROPENEM VERSUS COMBINATION THERAPY WITH CEFTAZIDIME PLUS AMIKACIN AS EMPIRIC THERAPY FOR FEVER IN GRANULOCYTOPENIC PATIENTS WITH CANCER. THE INTERNATIONAL ANTIMICROBIAL THERAPY COOPERATIVE GROUP OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER AND THE GRUPPO ITALIANO MALATTIE EMATOLOGICHE MALIGNE DELL'ADULTO INFECTION PROGRAM,” ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 40, no. -, pp. 1108–1115, 1996, [Online]. Available: https://sid.ir/paper/558941/en